Malignant Hyperthermia - 10
The Malignant Hyperthermia Susceptible (MHS) Patient
A simple three-step safe plan is suggested:
Yes, even outpatient surgery is acceptable, though some would extend the postoperative monitoring period to 2 to 4 hours.
Myopathies Associated with Malignant Hyperthermia
Two myopathies are clearly associated with MH:
central core disease (CCD) and
multiminicore disease (MmD).
Patients with these myopathies should be treated as malignant hyperthermia susceptible.